Big Molecule Watch
- Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program May 15, 2025 Amy Tso|Alexandra Lu
- President Trump Issues Two Executive Orders Concerning the Affordability and Accessibility of Drugs May 15, 2025 Timothy Beavers|Matt Wetzel|Natasha Daughtrey|Kevin DeJong|Elizabeth Mulkey
- EMA Issues Positive CHMP Opinions for Biocon’s Denosumab Biosimilars May 9, 2025 Alison Siedor
- District of New Jersey Denies Preliminary Injunction in Ustekinumab Breach of Contract Case May 2, 2025 Riley Wyberg
- EmblemHealth Files Class Action Antitrust Against Alexion Related to Eculizumab April 30, 2025 Sam Herron
- CuraTeQ Biologics’ Trastuzumab biosimilar Receives Positive Opinion in Europe April 30, 2025 Beth Ashbridge
- Update on Regeneron’s Supplemental BLA for EYLEA HD April 29, 2025 Daniel Farraye
- Regeneron, Mylan, and Biocon Settle in Aflibercept BPCIA Litigation April 28, 2025 Allegra Padula
- Celltrion Adalimumab Biosimilar Granted Interchangeability Designation April 18, 2025 Zachariah Holmes
- FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs April 15, 2025 Darlene Staines